A Study of PEG-EPO Injection (CHO Cells) for Maintenance Therapy of Patients With Renal Anemia .
Clinical trial NCT05629598 · UNKNOWN
Trial details
- NCT number
- NCT05629598
- Sponsor
- Angde Biotech Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-13
- Primary completion
- 2023-03-17
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.